Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease

Denton, 2017, Systemic sclerosis, Lancet, 390, 1685, 10.1016/S0140-6736(17)30933-9 Giacomelli, 2017, Interstitial lung disease in systemic sclerosis: current and future treatment, Rheumatol. Int., 37, 853, 10.1007/s00296-016-3636-7 Elhai, 2017, Mapping and predicting mortality from systemic sclerosis, Ann. Rheum. Dis., 76, 1897, 10.1136/annrheumdis-2017-211448 van Laar, 2014, Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial, JAMA, 311, 2490, 10.1001/jama.2014.6368 Sullivan, 2018, Myeloablative autologous stem-cell transplantation for severe scleroderma, N. Engl. J. Med., 378, 35, 10.1056/NEJMoa1703327 Burt, 2011, Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial, Lancet, 378, 498, 10.1016/S0140-6736(11)60982-3 van den Hoogen, 2013, Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative, Arthritis Rheum., 65, 2737, 10.1002/art.38098 Humbert, 2009, The 4th world symposium on pulmonary hypertension. Introduction, J. Am. Coll. Cardiol., 54, S1, 10.1016/j.jacc.2009.04.013 Goh, 2008, Interstitial lung disease in systemic sclerosis: a simple staging system, Am. J. Respir. Crit. Care Med., 177, 1248, 10.1164/rccm.200706-877OC Elhai, 2012, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, 51, 1017, 10.1093/rheumatology/ker269 Hao, 2017, Early mortality in a multinational systemic sclerosis inception cohort, Arthritis Rheumatol., 69, 1067, 10.1002/art.40027 van Bijnen, 2020, Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study, Ann. Rheum. Dis., 79, 1084, 10.1136/annrheumdis-2020-217058 Tyndall, 2010, Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Ann. Rheum. Dis., 69, 1809, 10.1136/ard.2009.114264 Pokeerbux, 2019, Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature, Arthritis Res. Ther., 21, 86, 10.1186/s13075-019-1867-1 Cottin, 2019, Interstitial lung disease associated with systemic sclerosis (SSc-ILD), Respir. Res., 20, 13, 10.1186/s12931-019-0980-7 Sierra-Sepulveda, 2019, Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast, BioMed Res. Int., 2019, 10.1155/2019/4569826 Harris, 2018, Therapeutic plasma exchange for the treatment of systemic sclerosis: a comprehensive review and analysis, J. Scleroderma Related Disorders, 3, 132, 10.1177/2397198318758606 Tobal, 2021, Vascular remodeling in pulmonary arterial hypertension: the potential involvement of innate and adaptive immunity, Front. Med., 8, 10.3389/fmed.2021.806899 Denton, 2015, Advances in pathogenesis and treatment of systemic sclerosis, Clin. Med., 15, s58, 10.7861/clinmedicine.15-6-s58 Forestier, 2018, Altered B lymphocyte homeostasis and functions in systemic sclerosis, Autoimmun. Rev., 17, 244, 10.1016/j.autrev.2017.10.015 Maehara, 2020, Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis, J. Clin. Invest., 130, 2451, 10.1172/JCI131700 Kowal-Bielecka, 2017, Update of EULAR recommendations for the treatment of systemic sclerosis, Ann. Rheum. Dis., 76, 1327, 10.1136/annrheumdis-2016-209909 Tyndall, 2019, Hematopoietic stem cell transplantation for systemic sclerosis: review of current status, BioDrugs, 33, 401, 10.1007/s40259-019-00364-3